---
title: "CK Life Sciences Int'l., (Holdings) Inc. (00775.HK)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/00775.HK.md"
symbol: "00775.HK"
name: "CK Life Sciences Int'l., (Holdings) Inc."
industry: "Biotechnology"
---

# CK Life Sciences Int'l., (Holdings) Inc. (00775.HK)

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Location | HK Market |
| Website | [www.ck-lifesciences.com](https://www.ck-lifesciences.com) |

## Company Profile

CK Life Sciences Int'l., (Holdings) Inc., an investment holding company, researches, develops, manufactures, commercializes, and sells health and agriculture-related products in the Asia Pacific and North America. It manufactures and markets plant protection products and soluble fertilizers; manufac...

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-16T04:30:10.000Z

**Overall: D (0.65)**

**Industry**: Biotechnology

| Metric | Value |
|--------|-------|
| Industry Ranking | 41 / 53 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 2.10% |  |
| Net Profit YoY | -1391.84% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 2.21 |  |
| Dividend Ratio | 0.00% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 8.07B |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 5.49B |  |


**Multi Score**: D

#### Profit Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -7.26% | D |
| Profit Margin | -5.07% | D |
| Gross Margin | 30.46% | C |

#### Growth Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 2.10% | C |
| Net Profit YoY | -1391.84% | E |
| Total Assets YoY | 3.66% | C |
| Net Assets YoY | -8.99% | D |

#### Cash Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | -1972.99% | E |
| OCF YoY | 2.10% | C |

#### Operating Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.50 | C |

#### Debt Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 67.63% | D |


```chart-data:radar
{
  "title": "Longbridge Financial Score - CK Life Sciences Int'l., (Holdings) Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "D",
      "indicators": [
        {
          "name": "ROE",
          "value": "-7.26%",
          "rating": "D"
        },
        {
          "name": "Profit Margin",
          "value": "-5.07%",
          "rating": "D"
        },
        {
          "name": "Gross Margin",
          "value": "30.46%",
          "rating": "C"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "D",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "2.10%",
          "rating": "C"
        },
        {
          "name": "Net Profit YoY",
          "value": "-1391.84%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "3.66%",
          "rating": "C"
        },
        {
          "name": "Net Assets YoY",
          "value": "-8.99%",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "D",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "-1972.99%",
          "rating": "E"
        },
        {
          "name": "OCF YoY",
          "value": "2.10%",
          "rating": "C"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "C",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.50",
          "rating": "C"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "D",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "67.63%",
          "rating": "D"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | BEONE MEDICINES (HK.6160) | C | A | B | C | A | B |
| 02 | INNOVENT BIO (HK.1801) | B | A | C | B | A | B |
| 03 | 3SBIO (HK.1530) | A | B | C | A | C | B |
| 04 | BIOCYTOGEN-B (HK.2315) | A | A | C | D | B | B |
| 05 | HBM HOLDINGS-B (HK.2142) | A | A | C | B | B | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -29.00 | 51/70 | - | - | - |
| PB | 2.21 | 14/70 | 2.46 | 2.30 | 2.16 |
| PS (TTM) | 1.47 | 3/70 | 1.62 | 1.50 | 1.43 |
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview](https://longbridge.com/en/quote/00775.HK/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/00775.HK/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/00775.HK/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.